Home > Insider Trading > La Jolla Pharmaceutical Co

La Jolla Pharmaceutical Co (LJPC)

Market is closed

Get Email Alerts

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

Get Email Alerts

News

First
<< Previous
11 - 17

13G Filing: Perceptive Advisors and La Jolla Pharmaceutical Co (LJPC)

The remainder of this cover page shall be filled out for a reporting persons initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information...

Keep Reading →

December 18th, 2017 - Hedge Funds

Hedge Funds Are Betting On La Jolla Pharmaceutical Company (LJPC)

It is already common knowledge that individual investors do not usually have the necessary resources and abilities to properly research an investment opportunity.

Keep Reading →

December 12th, 2016 - Hedge Funds News

13G Filing: Visium Asset Management Has Nearly Doubled Its Stake in La Jolla Pharmaceutical Co (LJPC)

We are seeing a boatload of 13G filing activity at the moment and investment firms disclose their positions as of the end of 2015 (we are not publishing these filings, as they are outdated).

Keep Reading →

February 12th, 2016 - Hedge Funds News

Is La Jolla Pharmaceutical Company (LJPC) A Good Stock To Buy?

It seems that the masses and most of the financial media hate hedge funds and what they do, but why is this hatred of hedge funds so prominent? At the end of the day, these asset management firms do not...

Keep Reading →

December 14th, 2015 - Hedge Funds News

Why MeetMe Inc (MEET), La Jolla Pharmaceutical Co. (LJPC), & Sorrento Therapeutics Inc (SRNE) Surged Last Week

MeetMe Inc (NASDAQ:MEET), La Jolla Pharmaceutical Co. (NASDAQ:LJPC), and Sorrento Therapeutics Inc (NASDAQ:SRNE) experienced a formidable surge on the stock market last week.

Keep Reading →

June 29th, 2015 - Hedge Funds Market Movers News

Heron Therapeutics Inc (HRTX), La Jolla Pharmaceutical Company (LJPC), Salix Pharmaceuticals, Ltd. (SLXP) Are Tang Capital's Largest Bets in Q4

Kevin Tang's Tang Capital Partners is one of the funds that have already revealed their equity portfolios as of the end of last year.

Keep Reading →

January 29th, 2015 - Hedge Funds News

Broadfin Capital Initiates New Positions In Corium International Inc (CORI), AMAG Pharmaceuticals Inc. (AMAG) and La Jolla Pharmaceutical Company (LJPC)

In three recent filings, Kevin Kotler’s Broadfin Capital has revealed adding three companies: Corium International Inc (NASDAQ:CORI), AMAG Pharmaceuticals Inc.

Keep Reading →

April 17th, 2014 - Hedge Funds News